A vesesejtes rák: az ESMO klinikai gyakorlati irányelve diagnózishoz, kezeléshez és utánkövetéshez

Powles T (1), Albiges L (2), Bex A (3,4,5), Comperat E (6), Grünwald V (7), Kanesvaran R (8), Kitamura H (9), McKay R (10), Porta C (11,12),
Procopio G (13), Schmidinger M (14), Suarez C (15), Teoh J (16), de Velasco G (17), Young M (1,18), Gillessen S (19,20), az ESMO-irányelvek
bizottságának részéről
(1) Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK
(2) Université Paris Saclay, Institut Gustave Roussy, Villejuif, France
(3) Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London, UK
(4) Division of Surgery and Interventional Science, University College London, London, UK
(5) Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
(6) Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria
(7) Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany
(8) Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
(9) Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan
(10) Department of Medicine and Urology, University of California San Diego, La Jolla, USA
(11) Interdisciplinary Department of Medicine, University of Bari ‘A. Moro’, Bari
(12) Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari
(13) Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
(14) Department of Urology, Medical University of Vienna, Vienna, Austria
(15) Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital
Campus, Barcelona, Spain
(16) S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China
(17) Instituto de Investigación i+12 and Departamento de Oncología Médica, Hospital University 12 de Octubre, Madrid, Spain
(18) Barts Cancer Institute, Department of Experimental Cancer Medicine, Queen Mary University of London, London, UK
(19) Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland
(20) Università della Svizzera Italiana, Lugano, Switzerland